Related Experiment Video
Updated: Apr 5, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Elevated oxygen consumption rate in response to acute low-glucose stress: Metformin restores rate to normal level
Emmanuel D Williams1, Steven C Rogers1, Xiaomin Zhang1
1Donald W. Reynolds Institute on Aging and Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States.
Insights
Metformin helps manage blood glucose levels in older adults by restoring cellular oxygen consumption during low-glucose stress. This finding sheds light on hypoglycemia mechanisms and potential therapeutic strategies for cardiovascular disease.
Area of Science:
- Gerontology
- Metabolic research
- Cardiovascular disease
Background:
- Cardiovascular disease (CVD) is the leading cause of death in the US, especially in older adults.
- Hyperglycemia is linked to premature age-related diseases, including CVD.
- Hypoglycemia poses treatment challenges in elderly patients with high blood glucose, and its molecular mechanisms are unclear.
Purpose of the Study:
- To investigate the mitochondrial metabolic response to short-term and long-term low-glucose stress.
- To determine the effect of metformin on cellular metabolism under glucose stress.
Main Methods:
- Mitochondrial metabolic profiling was performed.
- Cells were subjected to short-term (up to 6 hours) and longer-term (12-24 hours) low-glucose stress.
- The impact of metformin, a mitochondrial complex I inhibitor, was assessed.
Main Results:
- Metformin normalized elevated oxygen consumption rates during short-term glucose stress.
- This normalization restored oxygen consumption to levels seen in normal glucose conditions.
- The effect of metformin was partly attributed to the activation of 5' AMP-activated protein kinase (AMPK).
Conclusions:
- Metformin can mitigate metabolic dysregulation caused by short-term glucose stress.
- AMPK activation may play a role in metformin's beneficial effects on cellular metabolism during hypoglycemia.
- Understanding these mechanisms is crucial for managing CVD and age-related diseases in elderly populations.
Abstract:
Cardiovascular disease (CVD) continues to be the leading cause of mortality among all age demographics in the United States, with the highest occurrence in populations aged 65 and older. Glucose levels, particularly hyperglycemia, are associated with the premature onset of age-related diseases including CVD. A major challenge in the treatment of elderly patients with chronically elevated blood glucose is the frequency of hypoglycemic episodes. Molecular mechanisms of hypoglycemia remain unclear, but are associated with premature onset of age-related-diseases. Here we report a mitochondrial metabolic profile assessing short-term (up to six hours) and longer-term (12-24h) durations of low-glucose stress. We observed that the anti-diabetic biguanide and mitochondrial complex I inhibitor, metformin, can lower and restore the elevated oxygen consumption rate during shorter-term glucose stress to levels similar to that of cells cultured in normal glucose. This effect appears, in part, to involve activation of the 5' AMP-activated protein kinase (AMPK).
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Hypoglycemia and Glucagon
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

